TrademarkDir
BIOLINERX
LIVE

Serial Number

79377712

Owner

BioLineRx Ltd.

Attorney

Jeffrey H. Handelsman

Filing Date

May 29, 2023

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

BIOLINERX Trademark

Serial Number: 79377712 • Registration: 7484132

BIOLINERX is a trademark filed by BioLineRx Ltd. on May 29, 2023. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

BioLineRx Ltd. (5 trademarks)

2 HaMa'ayan Street

Entity Type: 99

Trademark Details

Filing Date

May 29, 2023

Registration Date

August 27, 2024

Published for Opposition

June 11, 2024

Goods & Services

Pharmaceutical product development services, namely, pharmaceutical product development through the discovery of compounds that helps for the treatment of a variety of diseases and symptoms; pharmaceutical product development services for a wide variety of diseases and symptoms, namely, neuropathic pain, acute kidney injury, inflammatory bowel disease, adult diabetes, weight loss among cancer patients, bacterial infections, rheumatoid arthritis, celiac disease, psoriasis, solid cancerous tumors, myocardial infarction, schizophrenia and prostate cancer; pharmaceutical product development services of new compounds for use in medicines for oncology patients; pharmaceutical research services; research and development services in the field of biotechnology

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 8, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 15, 2025 FICS
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Feb 15, 2025 OPNX
FINAL DISPOSITION PROCESSED
Feb 15, 2025 FIMP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 27, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jan 26, 2025 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 29, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 27, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 27, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 11, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jun 11, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 22, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 8, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 7, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 7, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 7, 2024 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 7, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
May 7, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 7, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 7, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 7, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 7, 2024 COAR
REFUSAL PROCESSED BY IB
Apr 2, 2024 RFNT
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Mar 17, 2024 LIME
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 13, 2024 RFCS
REFUSAL PROCESSED BY MPU
Mar 12, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 21, 2024 RFCR
NON-FINAL ACTION WRITTEN
Feb 20, 2024 CNRT
ASSIGNED TO EXAMINER
Feb 15, 2024 DOCK
LIMITATION OF GOODS RECEIVED FROM IB
Jan 28, 2024 LIMG
APPLICATION FILING RECEIPT MAILED
Sep 5, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 1, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 31, 2023 REPR

Related Trademarks

More from this Owner

BIOLINERX

BIOLINERX

BIOLINERX

BIOLINERX

BIOLINERX

BIOLINERX

BIOLINERX

BIOLINERX

APHEXDA

APHEXDA

APHEXDA logo

APHEXDA